Register
Login:
Share:
Email Facebook Twitter


Ariana forecast 47% rise in Kiziltepe gold production


Glaxosmithkline Share Price (GSK)



Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,445.00Bid: 1,445.40Ask: 1,445.80Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,433.00High: 1,445.80Low: 1,426.40Yesterday’s Close: 1,445.00

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1445.00
Share Price SpacerBid
1445.40
Share Price SpacerAsk
1445.80
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
7,098,046
Share Price SpacerOpen
1,433.00
Share Price SpacerHigh
1,445.80
Share Price SpacerLow
1,426.40
Share Price SpacerClose
1,445.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,958.96m £71,657.01m 1,500

52 Week High 1,724.50 52 Week High Date 22-JUN-2017
52 Week Low 1,236.40 52 Week Low Date 6-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
10,518 4,561,386 2,328,077 46.019 31.40 80.00 5.54


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: BP, Lloyds, Vodafone, Tesco, Barclays, RBS, HSBC, National Grid, BT, Astrazeneca

Users who hold GSK also hold: Vodafone, BP, Lloyds, National Grid, Royal Dutch Shell B, Tesco, HSBC, Aviva, Centrica, BT


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-Apr-18
17:38:13
1,438.474
3,000
Sell* 
1,445.40
1,445.80
43.15k
Trade Type:
Ordinary
Delayed publication

23-Apr-18
17:43:35
1,445.00
79,456
Sell* 
1,445.40
1,445.80
1.148M
Trade Type:
Ordinary
Delayed publication

23-Apr-18
17:54:39
1,444.331
28,722
Sell* 
1,445.40
1,445.80
414.84k
Trade Type:
Ordinary




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
01-Dec-17Exercise of option
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
1131GBX23817564623
09-Nov-17Buy
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
1364.18GBX1085883
09-Nov-17Buy
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
1364.18GBX917564376
View more Glaxosmithkline directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Thu 19:19DinokenRE: Glaxosmithkline on Watch Zone1,407.40No Opinion
Link does not appear in your post - says 'link removed'.
Try removing hyperlink before you post.
Alternatively, which site is this watch zone on ?
Thu 08:09Neyepudete22RE: Glaxosmithkline on Watch Zone1,430.00No Opinion
Thu 08:06Neyepudete22Glaxosmithkline on Watch Zone1,429.00No Opinion
Wed 22:02MrBeakyRE: RE: American operations of GSK.1,421.60No Opinion
Looking really solid now, should build from here
Wed 21:58TLWilliams.RE: American operations of GSK.1,421.60Buy
The restructuring continues - to good effect thus far:

GlaxoSmithKline said it had hired Kevin Sin from Roche£s Genentech unit to head worldwide business development for pharmaceuticals research and development. Sin, who will join GSK in San Francisco in July, has been responsible for oncology deal-making at Genentech since 2010. He will play a pivotal role as the British drugmaker seeks to strengthen its drug pipeline through acquisitions and licensing deals.
14 Apr '18NoodyAmerican operations of GSk1,420.00No Opinion
Tax changes very significant for JPM...

Hopefully will do the same for US based pharma operations of GSK

http://news.sky.com/story/donald-trumps-tax-cuts-see-jpmorgan-profits-soar-by-35-11328723

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Glaxosmithkline (GSK) >>

Please login or register to post a message on Share Chat.





Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 99,300 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries. As of August 2016 it had a market capitalisation of £81 billion the fourth largest on the London Stock Exchange



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.